Analystreport

Horizon Therapeutics Public Limited (NASDAQ: HZNP) had its price target lowered by analysts at BMO Capital Markets from $145.00 to $117.00.

Horizon Therapeutics Public Limited Company - Ordinary Shares  (HZNP) 
Last horizon therapeutics public limited company - ordinary shares earnings: 2/26 07:00 am Check Earnings Report